Rekha Hemrajani

CIK 1771213 · President and CEO · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$150.9K

Companies

7

Total Filings

27

Lifetime Open-Market Net

$135.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LBRX Director $28.42 $0 2 2026-06-05
ALXO Director 33,000 $1.58 $52.1K $103.4K 8 2026-01-21
MXCT Director 39,893 $1.12 $44.7K -$22.4K 7 2025-08-27
BIOA Director 3,000 $18.04 $54.1K $54.0K 3 2025-06-09
Adverum Biotechnologies, Inc. (ADVM) Delisted Director $4.36 $0 4 2020-06-25
Aravive, Inc. (ARAV) Delisted President and CEO 14,250 $0.04 $571 $0 2 2020-04-09
RCUS See Remarks $23.80 $0 1 2019-03-25

Recent Filings · Page 2 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-14 ALXO Grant (A) $0 EDGAR
2024-06-13 MXCT Grant (A) +21,367 $0 EDGAR
2023-06-23 MXCT Grant (A) $0 EDGAR
2023-06-22 ALXO Grant (A) $0 EDGAR
2023-03-21 MXCT Grant (A) $0 EDGAR
2022-07-08 MXCT Grant (A) $0 EDGAR
2022-06-16 ALXO Grant (A) $0 EDGAR
2021-08-11 MXCT Grant (A) $0 EDGAR
2021-06-15 ALXO Grant (A) $0 EDGAR
2020-07-21 ALXO Buy (P) +3,000 $57.0K EDGAR
Showing 1120 of 27
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.